Recursion.com Acquired for $904,000

It looks like George Kirikos may have uncovered another large domain name sale. In a tweet this morning, George reported that Recursion Pharmaceuticals acquired the one word Recursion.com domain name for $904,000:

The acquisition price information was found in the company’s SEC S-1 filing in advance of its IPO. On page F-15 of the S-1 under the “Intangible Asset Acquisitions” heading, the company reported the acquisition:

“Recursion Domain Name

In December 2020, the Company purchased the Recursion domain name for cash consideration of $904. The purchase price was capitalized as an intangible asset with an indefinite useful life.”

As with most corporate filings, the financial figures are in thousands, so “$904” means $904,000 USD. The company doesn’t specifically mention Recursion.com in that section, but Recursion.com is mentioned twice in the S-1 filing.

It is difficult to track the ownership history of this domain name in Whois records due to Whois privacy and GDPR redaction. It looks like it had been owned by a New York company at some point prior to the acquisition.

I added the sale of Recursion.com to the list of recent publicly reported one word .com domain name sales, and I am sure it will be added to DNJournal and NameBio where it will rank amongst the largest public domain name sales of 2020.

Elliot Silver
Elliot Silver
About The Author: Elliot Silver is an Internet entrepreneur and publisher of DomainInvesting.com. Elliot is also the founder and President of Top Notch Domains, LLC, a company that has closed eight figures in deals. Please read the DomainInvesting.com Terms of Use page for additional information about the publisher, website comment policy, disclosures, and conflicts of interest. Reach out to Elliot: Twitter | Facebook | LinkedIn

2 COMMENTS

    • Well, considering that we’re talking about a pharmaceutical company, I guess the word recursion can be defined as “the process of covertly making you sick with drugs, and then gaining a recurring customer who comes back perpetually with lots of money for your drugs or they’ll die, until you suck out lots of money and they’ll die anyway”. Yep, that’s it.

      So… who wants their experimental mRNA emergency use authorized drug they falsely label as vaccine?

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Recent Posts

Squadhelp Adds Escrow.com as a Payment Option

1
Squadhelp has added Escrow.com as a payment option for buyers. The addition of the Escrow.com option was shared by ARIYAS on X this morning: 👍...

Some Thoughts on .AI Domain Names

14
There is no question that .AI domain names have become a hot topic of late. With considerable amounts of venture funding flowing into AI...

Handoff to Dan on Imported Leads Can be Confusing

0
I've been using the lead import option at Dan.com more regularly. Although the 5% commission is not ideal, transactions tend to move more quickly...

ArtificialIntelligence.com Goes Up for Sale

11
I tried to buy the ArtificialIntelligence.com domain name multiple times over the last 10 years. The emails I sent to the registrant went unanswered,...

EU Gives More IP Protection to Food & Drink Producers

0
Did you know that some well-known food and drink varieties are protected intellectual property regulations? Popular types of drinks and foods that are protected...